|
🐜
|
Defining the clinical course of multiple sclerosis
32 auth.
F. Lublin,
S. Reingold,
Jeffrey A. Cohen,
G. Cutter,
P. Sørensen,
A. Thompson,
J. Wolinsky,
L. Balcer,
B. Banwell,
F. Barkhof,
B. Bebo,
P. Calabresi,
M. Clanet,
G. Comi,
R. Fox,
...
M. Freedman,
A. Goodman,
M. Inglese,
L. Kappos,
B. Kieseier,
J. Lincoln,
C. Lubetzki,
Aaron E Miller,
X. Montalban,
P. O'Connor,
J. Petkau,
C. Pozzilli,
R. Rudick,
M. Sormani,
O. Stüve,
E. Waubant,
C. Polman
|
11 |
2014 |
11
🐜
|
|
🐢
|
The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis
11 auth.
V. Devonshire,
Y. Lapierre,
R. Macdonell,
C. Ramo-Tello,
F. Patti,
P. Fontoura,
...
L. Suchet,
R. Hyde,
I. Balla,
E. Frohman,
B. Kieseier
|
8 |
2011 |
8
🐢
|
|
🐜
|
Acute Disseminated Encephalomyelitis An Update
8 auth.
T. Menge,
B. Hemmer,
S. Nessler,
H. Wiendl,
O. Neuhaus,
H. Hartung,
...
B. Kieseier,
O. Stüve
|
8 |
2005 |
8
🐜
|
|
🐜
|
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
11 auth.
P. Calabresi,
B. Kieseier,
D. Arnold,
L. Balcer,
A. Boyko,
J. Pelletier,
...
Shifang Liu,
Ying Zhu,
A. Seddighzadeh,
S. Hung,
A. Deykin
|
8 |
2014 |
8
🐜
|
|
🦁
|
The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis
B. Kieseier
|
8 |
2011 |
8
🦁
|
|
🐜
|
Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis
7 auth.
B. Schreiner,
M. Mitsdoerffer,
B. Kieseier,
Lieping Chen,
H. Hartung,
M. Weller,
...
H. Wiendl
|
8 |
2004 |
8
🐜
|
|
🐜
|
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
99 auth.
J. Kuhle,
G. Disanto,
R. Dobson,
R. Adiutori,
L. Bianchi,
J. Topping,
J. Bestwick,
U. Meier,
M. Marta,
G. Costa,
T. Runia,
E. Evdoshenko,
N. Lazareva,
E. Thouvenot,
P. Iaffaldano,
...
V. Direnzo,
M. Khademi,
F. Piehl,
M. Comabella,
M. Sombekke,
J. Killestein,
H. Hegen,
S. Rauch,
S. D'alfonso,
J. Álvarez-cermeño,
P. Kleinova,
D. Horáková,
Romy Roesler,
F. Lauda,
S. Llufriu,
Timuçin Avşar,
U. Uygunoğlu,
A. Altıntaş,
S. Saip,
T. Menge,
C. Rajda,
R. Bergamaschi,
N. Moll,
M. Khalil,
R. Marignier,
I. Dujmovic,
Henrik Larsson,
C. Malmeström,
E. Scarpini,
C. Fenoglio,
S. Wergeland,
A. Laroni,
Viviana Annibali,
S. Romano,
A. Martínez,
A. Carrá,
M. Salvetti,
A. Uccelli,
Ø. Torkildsen,
K. Myhr,
D. Galimberti,
K. Rejdak,
J. Lycke,
J. Frederiksen,
J. Drulovic,
C. Confavreux,
D. Brassat,
C. Enzinger,
S. Fuchs,
I. Boscá,
J. Pelletier,
C. Picard,
E. Colombo,
D. Franciotta,
T. Derfuss,
R. Lindberg,
Ö. Yaldizli,
L. Vécsei,
B. Kieseier,
H. Hartung,
P. Villoslada,
A. Siva,
A. Saiz,
H. Tumani,
E. Havrdová,
L. Villar,
M. Leone,
N. Barizzone,
F. Deisenhammer,
C. Teunissen,
X. Montalban,
M. Tintoré,
T. Olsson,
M. Trojano,
S. Lehmann,
G. Castelnovo,
Lapin Sv,
R. Hintzen,
L. Kappos,
R. Furlan,
V. Martinelli,
G. Comi,
S. Ramagopalan,
G. Giovannoni
|
8 |
2015 |
8
🐜
|
|
🐬
|
The role of macrophages in immune-mediated damage to the peripheral nervous system
R. Kiefer,
B. Kieseier,
G. Stoll,
H. Hartung
|
8 |
2001 |
8
🐬
|
|
🦁
|
Assessing walking disability in multiple sclerosis
B. Kieseier,
C. Pozzilli
|
8 |
2012 |
8
🦁
|
|
🐬
|
Immunopathogenesis and immunotherapy of multiple sclerosis
B. Hemmer,
S. Nessler,
Dun Zhou,
B. Kieseier,
H. Hartung
|
8 |
2006 |
8
🐬
|
|
🐢
|
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
11 auth.
N. Stefano,
L. Airas,
N. Grigoriadis,
H. Mattle,
J. O'Riordan,
C. Oreja-Guevara,
...
F. Sellebjerg,
B. Stankoff,
A. Walczak,
H. Wiendl,
B. Kieseier
|
8 |
2014 |
8
🐢
|
|
🐜
|
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
10 auth.
P. Sørensen,
A. Bertolotto,
G. Edan,
G. Giovannoni,
R. Gold,
E. Havrdová,
...
L. Kappos,
B. Kieseier,
X. Montalban,
T. Olsson
|
7 |
2012 |
7
🐜
|
